Varian Medical Systems (VAR) is Reiterated by Barrington Research to Outperform, Raises Price Target to $ 102

Varian Medical Systems (VAR) was Reiterated by Barrington Research to “Outperform” according to the research note released today. The brokerage firm has raised the Price Target to $ 102 from a previous price target of $93 . Barrington Research advised their investors in a research report released on Jul 28, 2016.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Varian Medical Systems opened for trading at $90.37 and hit $94.33 on the upside on Thursday, eventually ending the session at $94.03, with a gain of 6.25% or 5.53 points. The heightened volatility saw the trading volume jump to 18,94,607 shares. Company has a market cap of $8,953 M.

In a different news, on Jul 6, 2016, Dow R Wilson (President and CEO) sold 10,000 shares at $82.25 per share price. According to the SEC, on Jun 9, 2016, Ruediger Naumann-etienne (director) sold 1,000 shares at $84.83 per share price. On Jun 6, 2016, Mark R Laret (director) sold 1,545 shares at $83.47 per share price, according to the Form-4 filing with the securities and exchange commission.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Varian Medical Systems

Leave a Reply

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.